MRD Testing Practices in Colorectal Cancer

Opinion
Video

GI medical oncologists discuss MRD testing practices in colorectal cancer and provide insights on challenges associated with testing.

Recent Videos
Findings from the CodeBreak 300 study have cemented sotorasib/panitumumab as a third-line treatment option for KRAS G12C-mutated colorectal cancer.
Sotorasib plus panitumumab may offer improved survival compared with previously approved treatment options in KRAS G12C-mutated colorectal cancer.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Related Content